For: | Karanjia RN, Crossey MME, Cox IJ, Fye HKS, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016; 22(45): 9880-9897 [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i45/9880.htm |
Number | Citing Articles |
1 |
Padmapani Padeniya, Dileepa Ediriweera, Arjuna P. De Silva, Madunil Niriella, Anuja Premawardhena. The association between steatosis and liver damage in transfusion‐dependent beta thalassaemia patients. British Journal of Haematology 2023; 200(4): 517 doi: 10.1111/bjh.18492
|
2 |
Jiejuan Lai, Shifang Jiang, Ling Shuai, Yujun Zhang, Renpei Xia, Quanyu Chen, Lianhua Bai. Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow. Stem Cell Research 2021; 55: 102477 doi: 10.1016/j.scr.2021.102477
|
3 |
Tarik Akar. Is serum angiotensin converting enzyme level a useful non-invasive marker for liver fibrosis in patients with chronic hepatitis C?. Revista da Associação Médica Brasileira 2018; 64(3): 224 doi: 10.1590/1806-9282.64.03.224
|
4 |
Henning Ulrich, Talita Glaser, Andrew P. Thomas. Purinergic signaling in liver disease: calcium signaling and induction of inflammation. Purinergic Signalling 2024; doi: 10.1007/s11302-024-10044-9
|
5 |
Sue C. Kaste, Anurag Arora. Imaging in Pediatric Oncology. Pediatric Oncology 2019; : 223 doi: 10.1007/978-3-030-03777-2_12
|
6 |
Mayur Virarkar, Ajaykumar C. Morani, Melissa W. Taggart, Priya Bhosale. Liver Fibrosis Assessment. Seminars in Ultrasound, CT and MRI 2021; 42(4): 381 doi: 10.1053/j.sult.2021.03.003
|
7 |
Ken Shirabe, Yuki Bekki, Dolgormaa Gantumur, Kenichiro Araki, Norihiro Ishii, Atsushi Kuno, Hisashi Narimatsu, Masashi Mizokami. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. Journal of Gastroenterology 2018; 53(7): 819 doi: 10.1007/s00535-017-1425-z
|
8 |
Jin Hyun Park, In Sil Choi, Kyung-Do Han, Hyunkyung Park, Ki Hwan Kim, Jin-Soo Kim. Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study. Clinical Breast Cancer 2020; 20(4): e450 doi: 10.1016/j.clbc.2020.02.004
|
9 |
Satoshi Takakusagi, Ken Sato, Kyoko Marubashi, Kazuko Kizawa, Takashi Kosone, Satoru Kakizaki, Hitoshi Takagi, Toshio Uraoka. Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C. Biomedicines 2021; 9(6): 660 doi: 10.3390/biomedicines9060660
|
10 |
Zhi Zhang, Huiqing Wen, Bangjian Peng, Jun Weng, Fanhong Zeng. HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axis. Molecular Therapy - Nucleic Acids 2021; 24: 711 doi: 10.1016/j.omtn.2021.01.026
|
11 |
Fanyu Zhao, Yidi Chen, Ting Zhou, Cheng Tang, Jiang Huang, Huiting Zhang, Stephan Kannengiesser, Liling Long. Application of the magnetic resonance 3D multiecho Dixon sequence for quantifying hepatic iron overload and steatosis in patients with thalassemia. Magnetic Resonance Imaging 2024; 111: 28 doi: 10.1016/j.mri.2024.03.015
|
12 |
Fabio Lucio Stahlschmidt, Jean Rodrigo Tafarel, Carla Martinez Menini-Stahlschmidt, Cristina Pellegrino Baena, Guy Cloutier. Hepatorenal index for grading liver steatosis with concomitant fibrosis. PLOS ONE 2021; 16(2): e0246837 doi: 10.1371/journal.pone.0246837
|
13 |
Shengnan Ding, Weimin Yang, Xiaodong Sun, Yan Guo, Guangjie Zhao, Jinzhu Yang, Lei Zhang, Guoyue Lv, Kwang Gi Kim. Computed Tomography-Based Radiomic Analysis for Preoperatively Predicting the Macrovesicular Steatosis Grade in Cadaveric Donor Liver Transplantation. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2491023
|
14 |
Helle Kristensen, Nina Kimer, Søren Møller. Indications and methods for measuring portal hypertension in cirrhosis. Scandinavian Journal of Gastroenterology 2022; 57(10): 1149 doi: 10.1080/00365521.2022.2065889
|
15 |
Erika Ramos-Tovar, Pablo Muriel. Antioxidants. Vitamins and Hormones 2023; 121: 271 doi: 10.1016/bs.vh.2022.09.006
|
16 |
Mario Jesus Trejo, Kristin E. Morrill, Yann C. Klimentidis, David O. Garcia. Examining genetic associations with hepatic steatosis in Mexican-origin adults. Annals of Hepatology 2023; 28(5): 101120 doi: 10.1016/j.aohep.2023.101120
|
17 |
Nicky Somers, Elisabeth Vandekerckhove, Anja Geerts, Helena Degroote, Sander Lefere, Lindsey Devisscher, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst. Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection. Acta Clinica Belgica 2023; 78(2): 96 doi: 10.1080/17843286.2022.2072110
|
18 |
Long Zhu, Wenqun Gou, Lijia Ou, Binjie Liu, Manyi Liu, Hui Feng. Role and new insights of microfibrillar‐associated protein 4 in fibrotic diseases. APMIS 2024; 132(2): 55 doi: 10.1111/apm.13358
|
19 |
Chloe Wong, Clyve Yu Leon Yaow, Cheng Han Ng, Yip Han Chin, Yi Fen Low, Amanda Yuan Ling Lim, Mark Dhinesh Muthiah, Chin Meng Khoo. Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.609135
|
20 |
Juan Moreno-Vedia, Roser Rosales, Enrique Ozcariz, Dídac Llop, Maribel Lahuerta, María Benavent, Ricardo Rodríguez-Calvo, Núria Plana, Angels Pedragosa, Lluís Masana, Antoni Castro, Daiana Ibarretxe, Josefa Girona. Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.775677
|
21 |
Yi-Chun Liao, Juei-Seng Wu, Hsuan-Wen Chou, Hsin-Yu Kuo, Chun-Te Lee, Hung-Tsung Wu, Chung-Hao Li, Horng-Yih Ou. Serum Cardiotrophin-1 Concentration Is Negatively Associated with Controlled Attenuation Parameters in Subjects with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2023; 12(7): 2741 doi: 10.3390/jcm12072741
|
22 |
Yanli Jiang, Fengxian Fan, Pengfei Zhang, Jun Wang, Wenjing Huang, Yu Zheng, Ruiqing Guo, Shaoyu Wang, Jing Zhang. Staging liver fibrosis by a continuous-time random-walk diffusion model. Magnetic Resonance Imaging 2024; 105: 100 doi: 10.1016/j.mri.2023.11.009
|
23 |
David Hudson, Tamoor Afzaal, Hasan Bualbanat, Raaed AlRamdan, Nisha Howarth, Pavithra Parthasarathy, Alia AlDarwish, Emily Stephenson, Yousef Almahanna, Maytham Hussain, Luis Antonio Diaz, Juan Pablo Arab. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241276334
|
24 |
Steven C. Moore, Kaitlyn M. Mazzilli, Joshua N. Sampson, Charles E. Matthews, Brian D. Carter, Mary C. Playdon, Ying Wang, Victoria L. Stevens. A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II. Metabolites 2021; 11(2): 95 doi: 10.3390/metabo11020095
|
25 |
Mariëlle Walraven, Boris Hinz. Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer. Matrix Biology 2018; : 205 doi: 10.1016/j.matbio.2018.02.020
|
26 |
Anna Egresi, Anna Blázovics, Gabriella Lengyel, Adrienn Gréta Tóth, Barbara Csongrády, Zsuzsanna Jakab, Krisztina Hagymási. Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography. Diagnostics 2024; 14(17): 1945 doi: 10.3390/diagnostics14171945
|
27 |
Falide Atabieke, Xiu-Juan Li, Ailikamu Aierken, Jian Li, Yu Zhang, Yierzhati Aizezi, Hong-Liang Gao, Zhi-Qiang Zhang. Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017–2020. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1330221
|
28 |
Gianpaolo Vidili, Marco Arru, Pierluigi Meloni, Giuliana Solinas, Sebastiana Atzori, Ivana Maida. Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease. Journal of Clinical Medicine 2024; 13(14): 4061 doi: 10.3390/jcm13144061
|
29 |
Tzu-chia Kuo, Yang-bor Lu, Chieh-lun Yang, Bin Wang, Lin-xin Chen, Ching-ping Su. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03095-6
|
30 |
Sofia Maria Tarchi, Mary Salvatore, Philip Lichtenstein, Thillai Sekar, Kathleen Capaccione, Lyndon Luk, Hiram Shaish, Jasnit Makkar, Elise Desperito, Jay Leb, Benjamin Navot, Jonathan Goldstein, Sherelle Laifer, Volkan Beylergil, Hong Ma, Sachin Jambawalikar, Dwight Aberle, Belinda D’Souza, Stuart Bentley-Hibbert, Monica Pernia Marin. Radiology of fibrosis part II: abdominal organs. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05346-w
|
31 |
Ariane De Villers-Lacasse, Martine Paquette, Alexis Baass, Sophie Bernard. Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes. Journal of Clinical Lipidology 2023; 17(4): 475 doi: 10.1016/j.jacl.2023.05.096
|
32 |
Timian M. Godfrey, Edgar A. Villavicencio, Kimberly Barra, Priscilla R. Sanderson, Kimberly Shea, Xiaoxiao Sun, David O. Garcia. Advancing Liver Cancer Prevention for American Indian Populations in Arizona: An Integrative Review. International Journal of Environmental Research and Public Health 2022; 19(6): 3268 doi: 10.3390/ijerph19063268
|
33 |
Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, Adrian Dobrinescu, Vlad Pădureanu, Venera Cristina Dinescu, Mircea-Cătălin Forțofoiu. Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis. Metabolites 2024; 14(4): 198 doi: 10.3390/metabo14040198
|
34 |
Asuman Nur Karhan, Hayriye Hizarcioglu-Gulsen, Ersin Gumus, Zuhal Akçören, Hülya Demir, İnci Nur Saltik-Temizel, Diclehan Orhan, Hasan Özen. Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism?. Pediatric Gastroenterology, Hepatology & Nutrition 2021; 24(6): 518 doi: 10.5223/pghn.2021.24.6.518
|
35 |
Felipe David Mendonça Chaim, Lívia Bitencourt Pascoal, Fábio Henrique Mendonça Chaim, Bruna Biazon Palma, Tiago Andrade Damázio, Larissa Bastos Eloy da Costa, Rita Carvalho, Everton Cazzo, Martinho Antônio Gestic, Murillo Pimentel Utrini, Marciane Milanski, Elinton Adami Chaim, Raquel Franco Leal. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65556-2
|
36 |
Shereen A Saleh, Mohamed M Salama, Marwan M Alhusseini, Ghada A Mohamed. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World Journal of Gastroenterology 2020; 26(21): 2864-2876 doi: 10.3748/wjg.v26.i21.2864
|
37 |
Tariq Aziz, Ayaz Ali Khan, Athina Tzora, Chrysoula (Chrysa) Voidarou, Ioannis Skoufos. Dietary Implications of the Bidirectional Relationship between the Gut Microflora and Inflammatory Diseases with Special Emphasis on Irritable Bowel Disease: Current and Future Perspective. Nutrients 2023; 15(13): 2956 doi: 10.3390/nu15132956
|
38 |
Satoshi Takakusagi, Hitoshi Takagi, Yozo Yokoyama, Kyoko Marubashi, Kazuko Kizawa, Takashi Kosone, Ken Sato, Satoru Kakizaki, Toshio Uraoka. Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis. Clinical Journal of Gastroenterology 2020; 13(5): 896 doi: 10.1007/s12328-020-01103-w
|
39 |
Andrew Yang, Melinda Nguyen, Irene Ju, Anthony Brancatisano, Brendan Ryan, David van der Poorten. Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93294-6
|
40 |
Xinghang Dai, Yujun Zeng, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo. Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis. Advanced NanoBiomed Research 2021; 1(7) doi: 10.1002/anbr.202000091
|
41 |
Takako Inoue, Yuji Tsuzuki, Etsuko Iio, Noboru Shinkai, Kayoko Matsunami, Kei Fujiwara, Kentaro Matsuura, Shunsuke Nojiri, Yasuhito Tanaka. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker <i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced Fibrosis. Japanese Journal of Infectious Diseases 2018; 71(3): 177 doi: 10.7883/yoken.JJID.2017.459
|
42 |
Yutian Lu, Qiongdan Wang, Lisha Yu, XueRui Yin, Huijie Yang, Xi Xu, Ying Xia, Yue Luo, Ying Peng, Qigui Yu, Zhanguo Chen, Jian Yu, Meimei Lai, Nan Wu, Xiao‐Ben Pan, Xiaoqun Zheng. Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non‐alcoholic fatty liver disease. Journal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23285
|
43 |
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Shintaro Ogawa, Kei Fujiwara, Shunsuke Nojiri, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents. Hepatology Research 2022; 52(11): 919 doi: 10.1111/hepr.13823
|
44 |
Devis Pascut, Pablo J. Giraudi, Cristina Banfi, Stefania Ghilardi, Claudio Tiribelli, Adele Bondesan, Diana Caroli, Alessandro Minocci, Graziano Grugni, Alessandro Sartorio. Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1254778
|
45 |
Run Zhou, Luping Yang, Binbin Zhang, Yunpeng Gu, Tingting Kong, Wei Zhang, Lei Sun, Chunlan Liu, Ningjia Kong, Jie Li, Junping Shi. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2023; 30(10): 793 doi: 10.1111/jvh.13872
|
46 |
Han Young Kim, Seunglee Kwon, Wooram Um, Sol Shin, Chan Ho Kim, Jae Hyung Park, Byung‐Soo Kim. Functional Extracellular Vesicles for Regenerative Medicine. Small 2022; 18(36) doi: 10.1002/smll.202106569
|
47 |
Haya Al-Sulaiti, Ilhame Diboun, Maha V. Agha, Fatima F. S. Mohamed, Stephen Atkin, Alex S. Dömling, Mohamed A. Elrayess, Nayef A. Mazloum. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2096-8
|
48 |
Jing Zhou, Jing Fan, Xiaoyun Zhang, Lili You, Diaozhu Lin, Chulin Huang, Feng Li, Kan Sun. Fatty Liver Index and Its Association with 10-Year Atherosclerotic Cardiovascular Disease Risk: Insights from a Population-Based Cross-Sectional Study in China. Metabolites 2023; 13(7): 850 doi: 10.3390/metabo13070850
|
49 |
Murtadha Al-Khabori, Shahina Daar, Said A. Al-Busafi, Humoud Al-Dhuhli, AlGhalya A. Alumairi, Moez Hassan, Sara Al-Rahbi, Umaima Al-Ajmi. Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography. Hematology 2019; 24(1): 183 doi: 10.1080/10245332.2018.1540518
|
50 |
Gnyana Ranjan Parida, Gurudutta Pattnaik, Amulyaratna Behera. Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight. Research Journal of Pharmacy and Technology 2021; : 6147 doi: 10.52711/0974-360X.2021.01066
|
51 |
Xiang Huang, Lihui Wang, Mingyu Meng, Shijun Zhang, Thi Thai Hoa Pham, Luhui Jiang, Lixiu Chen, Yuchun Li, Xing Zhou, Luhui Qin, Xingchun Wu, Chunlin Zou, Renbin Huang. Extract of Averrhoacarambola L. (Oxalidaceae) roots ameliorates carbon tetrachloride-induced hepatic fibrosis in rats. Biomedicine & Pharmacotherapy 2020; 121: 109516 doi: 10.1016/j.biopha.2019.109516
|
52 |
Xinyu Hong, Zaixin Guo, Qi Yu. Hepatic steatosis in women with polycystic ovary syndrome. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01456-6
|
53 |
Alexandra Wuopio, Brett M. Baker, Benjamin Koethe, Martin D. Goodman, Reuben Shin, Nikolay Bugaev, Dmitry Nepomnayshy, Woon Cho Kim, Thomas Schnelldorfer. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery?. Obesity Surgery 2024; 34(3): 769 doi: 10.1007/s11695-024-07070-2
|
54 |
Claruza Braga Holanda Lavor, Antonio Brazil Viana Júnior, Francisco das Chagas Medeiros. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 2022; 44(03): 287 doi: 10.1055/s-0041-1741032
|
55 |
Alejandro Villasante, Carolina Ramírez, Héctor Rodríguez, Patricio Dantagnan, Adrián Hernández, Elías Figueroa, Jaime Romero. Dietary carbohydrate-to-protein ratio influences growth performance, hepatic health and dynamic of gut microbiota in atlantic salmon (Salmo salar). Animal Nutrition 2022; 10: 261 doi: 10.1016/j.aninu.2022.04.003
|
56 |
Christopher J Welman, Jacqualine Saunders, Marilyn Zelesco, Steven Abbott, Glenn Boardman, Oyekoya T Ayonrinde. Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation. Journal of Medical Imaging and Radiation Oncology 2023; 67(1): 45 doi: 10.1111/1754-9485.13412
|
57 |
Kan Sun, Diaozhu Lin, Feng Li, Yiqin Qi, Wanting Feng, Li Yan, Chaogang Chen, Meng Ren, Dan Liu. Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China. BMJ Open 2018; 8(1): e019097 doi: 10.1136/bmjopen-2017-019097
|
58 |
Hiroki Nishikawa, Takashi Nishimura, Hirayuki Enomoto, Yoshinori Iwata, Akio Ishii, Yuho Miyamoto, Noriko Ishii, Yukihisa Yuri, Ryo Takata, Kunihiro Hasegawa, Chikage Nakano, Kazunori Yoh, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Shuhei Nishiguchi, Hiroko Iijima. Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases. Nutrients 2017; 9(6): 620 doi: 10.3390/nu9060620
|
59 |
Rohit Loomba, Eric Lawitz, Parvez S. Mantry, Saumya Jayakumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, C. Stephen Djedjos, Ling Han, Robert P. Myers, G. Mani Subramanian, John G. McHutchison, Zachary D. Goodman, Nezam H. Afdhal, Michael R. Charlton. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology 2018; 67(2): 549 doi: 10.1002/hep.29514
|
60 |
T. Banzato, F. Bonsembiante, L. Aresu, M.E. Gelain, S. Burti, A. Zotti. Use of transfer learning to detect diffuse degenerative hepatic diseases from ultrasound images in dogs: A methodological study. The Veterinary Journal 2018; 233: 35 doi: 10.1016/j.tvjl.2017.12.026
|
61 |
Christina N. Katsagoni, George V. Papatheodoridis, Panagiota Ioannidou, Melanie Deutsch, Alexandra Alexopoulou, Nikolaos Papadopoulos, Maria-Vasiliki Papageorgiou, Elizabeth Fragopoulou, Meropi D. Kontogianni. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. British Journal of Nutrition 2018; 120(2): 164 doi: 10.1017/S000711451800137X
|
62 |
Ruijie Cao, Shasha Zhang, Jing Li, Jingjing Zhang, Yufei Zhao, Pengqing Jiao, Cuiju Wang, Zhanjun Guo. Chinese Herbal Medicine-Induced Rapid Liver Cirrhosis: A Case Report. Hepatitis Monthly 2021; 21(8) doi: 10.5812/hepatmon.118934
|
63 |
Arthur Pearson, Paul‐Armand Dujardin, Louis d'Alteroche, Frédéric Patat, Béatrice Scotto, Fanny Dujardin, Cécile Bastard, Véronique Miette, Laurent Sandrin, Jean‐Pierre Remenieras. Vibration‐controlled transient elastography for noninvasive evaluation of liver steatosis. Medical Physics 2022; 49(3): 1507 doi: 10.1002/mp.15484
|